4 completed, 1 recruiting. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 4, Recruiting 1 |
Follow Abdominal Abscess: new trials by email Literature Review of Abdominal Abscess trials Research Report on Abdominal Abscess
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| APPI-Cost Trial for Perforated Appendicitis PVI, Usual Care - Perforated Appendicitis | Phase 4 | Recruiting | The University of Texas Health Science Center, Houston | 346 | 2025-04-07 | 2025-12-11 |
| Antibiotics for Klebsiella Liver Abscess Study Ciprofloxacin, Ceftriaxone, Trimethoprim/sulfamethoxazole - Liver Abscess, Pyogenic | Phase 4 | Completed | National University Hospital, Singapore | 152 | 2013-11-05 | 2018-08-27 |
| Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess Moxifloxacin (Avelox), ceftriaxone - Liver Abscess | Phase 4 | Completed | Kaohsiung Veterans General Hospital. | 24 | 2009-05-01 | 2015-12-02 |
| Study Evaluating the Safety and Efficacy of Tigecycline in Hospitalized Patients With cIAI tigecycline - Abdominal Abscess | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 50 | 2006-08-01 | 2009-07-07 |
| Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI) tigecycline, ceftriaxone plus metronidazole - Appendicitis, Cholecystitis | Phase 4 | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 473 | 2005-10-01 | 2013-02-25 |
Appendicitis (2) · Abscess (1) · Cholecystitis (1) · Diverticulitis (1) · Intraabdominal Infections (1) · Liver Abscess (1) · Liver Abscess, Pyogenic (1) · Peritonitis (1)
Infections (5) · Suppuration (5) · Abscess (4) · Digestive System Diseases (4) · Cecal Diseases (2) · Gastroenteritis (2) · Gastrointestinal Diseases (2) · Intestinal Diseases (2) · Liver Diseases (2) · Biliary Tract Diseases (1) · Diverticular Diseases (1) · Gallbladder Diseases (1) · Inflammation (1) · Intraabdominal Infections (1)
Ceftriaxone (3) · Tigecycline (2) · Ciprofloxacin (1) · Ertapenem (1) · Metronidazole (1) · Moxifloxacin (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1)
Wyeth is now a wholly owned subsidiary of Pfizer (2) · Kaohsiung Veterans General Hospital. (1) · National University Hospital, Singapore (1) · The University of Texas Health Science Center, Houston (1)
Taiwan (3) · Australia (1) · China (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Greece (1) · Hong Kong (1) · India (1) · Italy (1) · Philippines (1) · Portugal (1) · Saudi Arabia (1) · Singapore (1)
Dalya Ferguson, MD, MS (1) · Sophia Archuleta, MD (1) · Susan Shin-Jung Lee, M.D., M.Sc (1)
PMID 22439781, PMID 31641767, PMID 37328522
K12TR004908 (1)